Analysis for ARES
- 📈 Growth — 26/30
- 💰 Profitability — 15/20
- 🏦 Financial Health — 16/20
- 💵 Valuation — 14/20
- ⚠️ Risk — 6/10
Summary:
📈 Growth & Financial Trajectory
Over eight quarters, revenue rose from $841.97M to $1,293.66M, a roughly 54% gain. Net income rose from $216.41M to $241.72M (about 12%). The trajectory is positive on top line, though margins swing: negative in mid-2025, then a sharp rebound in late 2025 and into 2026. The eight-quarter path shows a constructive trend with a mix of quarters framed by improving scale and recurring fee-driven earnings.
💰 Margins & Cash Flow
Operating margins fluctuated from negative in several quarters to positive in late 2025 into 2026, with Q4 2025 near 20% and Q1–Q2 2026 around 9–10%. This suggests improving operating leverage as revenue grows. Operating cash flow was strong in several periods (roughly $2.0B in Q1 2025; $1.34B in Q3 2025) but volatility persisted, including downturns into 2026; financing activity provided support in some quarters while investing activity was outflows.
🛡️ Balance Sheet & Liquidity
Assets run around $27–$29B with current assets exceeding current liabilities, yielding a rough working-capital cushion of 1.4x. Equity remains around $8.0–8.6B and there is no material long-term debt reported in these quarters, contributing to resilience despite earnings volatility.
⚠️ Key Drivers & Risks
- Drivers: Recurring management fees and potential AUM growth; favorable market conditions may boost fee-related revenue.
- Risks: Revenue and margin sensitivity to market cycles; cash flow volatility and reliance on financing to fund activities.